Friday, October 7, 2016

Lanatoside C




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01AA06

CAS registry number (Chemical Abstracts Service)

0017575-22-3

Chemical Formula

C49-H76-O20

Molecular Weight

985

Therapeutic Category

Cardiac glycoside

Chemical Name

3ß-[4-O-ß-D-Glycopyranosyl-4-O-(3-O-acetyl-ß-D-digitoxopyranosyl)-4-O-ß-D-digitoxopyranosyl-ß-D-digitoxopyranosyl]-12ß,14-dihydroxy-5ß,14ß-card-20(22)-enolid (IUPAC)

Foreign Names

  • Lanatosidum C (Latin)
  • Lanatosid C (German)
  • Lanatoside C (French)
  • Lanatosido c (Spanish)

Generic Names

  • Lanatoside C (OS: DCIT, DCF, JAN, BAN)
  • Celanidum (IS)
  • Digilanid C (IS)
  • Lanacard (IS)
  • Lanatoside C (PH: F.U. IX, JP XIV, NF XIII, Ph. Franç. Xe édit, BP 1999)
  • Lanatosidum C (PH: Ph. Eur. 3, Ph. Int. 2)

Brand Names

  • Cedilanid
    Medview, Ghana; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria; Novartis, Sudan; Novartis, Tanzania; Novartis, Zimbabwe


  • Celandium-KMP
    Arterium, Georgia


  • Digilanogen C
    Astellas, Japan


  • Lanato C
    Kobayashi Kako, Japan


  • Lanatosido C
    Biosano, Chile; Sanderson, Chile


  • Lanatosido
    Sanderson, Peru

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment